Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial
Authors
Keywords
-
Journal
PEDIATRIC DIABETES
Volume 19, Issue 3, Pages 410-419
Publisher
Wiley
Online
2017-11-24
DOI
10.1111/pedi.12611
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current and future efforts toward the prevention of type 1 diabetes
- (2016) Laura Jacobsen et al. PEDIATRIC DIABETES
- The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study
- (2015) Jeffrey P. Krischer et al. DIABETOLOGIA
- Effects of High-Dose Oral Insulin on Immune Responses in Children at High Risk for Type 1 Diabetes
- (2015) Ezio Bonifacio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Baseline heterogeneity in glucose metabolism marks the risk for type 1 diabetes and complicates secondary prevention
- (2014) Helena Elding Larsson et al. ACTA DIABETOLOGICA
- GAD Autoantibody Affinity in Adult Patients With Latent Autoimmune Diabetes, the Study Participants of a GAD65 Vaccination Trial
- (2014) Stephanie Krause et al. DIABETES CARE
- Regulatory T cell phenotype and function 4 years after GAD-alum treatment in children with type 1 diabetes
- (2013) M. Pihl et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial
- (2013) S. Axelsson et al. DIABETES CARE
- Diagnosis and Classification of Diabetes Mellitus
- (2013) DIABETES CARE
- Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
- (2013) Anette G. Ziegler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study
- (2013) Cecilia Andersson et al. PEDIATRIC DIABETES
- GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus
- (2012) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes
- (2011) C. Andersson et al. AUTOIMMUNITY
- Reduced Prevalence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Young Children Participating in Longitudinal Follow-Up
- (2011) H. Elding Larsson et al. DIABETES CARE
- Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
- (2011) Diane K Wherrett et al. LANCET
- GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients
- (2010) Maria Hjorth et al. CLINICAL IMMUNOLOGY
- GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes
- (2009) C.-D. Agardh et al. DIABETOLOGIA
- Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
- (2008) Kirsti Näntö-Salonen et al. LANCET
- GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes
- (2008) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started